JP2022003099A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022003099A5 JP2022003099A5 JP2021171358A JP2021171358A JP2022003099A5 JP 2022003099 A5 JP2022003099 A5 JP 2022003099A5 JP 2021171358 A JP2021171358 A JP 2021171358A JP 2021171358 A JP2021171358 A JP 2021171358A JP 2022003099 A5 JP2022003099 A5 JP 2022003099A5
- Authority
- JP
- Japan
- Prior art keywords
- eye drop
- aqueous
- aqueous eye
- mpa
- viscosity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003889 eye drop Substances 0.000 claims 12
- 239000002997 ophthalmic solution Substances 0.000 claims 2
- 229940054534 ophthalmic solution Drugs 0.000 claims 2
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 1
- 206010013774 Dry eye Diseases 0.000 claims 1
- NMLMACJWHPHKGR-NCOIDOBVSA-N P(1),P(4)-bis(uridin-5'-yl) tetraphosphate Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@H]2O)O)COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N2C(NC(=O)C=C2)=O)O)O)C=CC(=O)NC1=O NMLMACJWHPHKGR-NCOIDOBVSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229950003529 diquafosol Drugs 0.000 claims 1
- 239000006196 drop Substances 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 239000002562 thickening agent Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024228577A JP7902251B2 (ja) | 2019-08-27 | 2024-12-25 | ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019154525 | 2019-08-27 | ||
| JP2019154525 | 2019-08-27 | ||
| JP2021521065A JP6966667B2 (ja) | 2019-08-27 | 2020-08-25 | ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521065A Division JP6966667B2 (ja) | 2019-08-27 | 2020-08-25 | ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024228577A Division JP7902251B2 (ja) | 2019-08-27 | 2024-12-25 | ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022003099A JP2022003099A (ja) | 2022-01-11 |
| JP2022003099A5 true JP2022003099A5 (enExample) | 2023-08-25 |
| JP7614069B2 JP7614069B2 (ja) | 2025-01-15 |
Family
ID=74685901
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521065A Active JP6966667B2 (ja) | 2019-08-27 | 2020-08-25 | ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 |
| JP2021171358A Active JP7614069B2 (ja) | 2019-08-27 | 2021-10-20 | ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 |
| JP2024228577A Active JP7902251B2 (ja) | 2019-08-27 | 2024-12-25 | ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521065A Active JP6966667B2 (ja) | 2019-08-27 | 2020-08-25 | ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024228577A Active JP7902251B2 (ja) | 2019-08-27 | 2024-12-25 | ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 |
Country Status (7)
| Country | Link |
|---|---|
| JP (3) | JP6966667B2 (enExample) |
| KR (2) | KR102656181B1 (enExample) |
| CN (2) | CN114286670B (enExample) |
| MY (1) | MY209059A (enExample) |
| PH (1) | PH12022550474A1 (enExample) |
| TW (1) | TWI848171B (enExample) |
| WO (1) | WO2021039748A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202007977RA (en) * | 2018-02-28 | 2020-09-29 | Santen Pharmaceutical Co Ltd | Ophthalmic composition comprising diquafosol and cationic polymer |
| JP6966667B2 (ja) * | 2019-08-27 | 2021-11-17 | 参天製薬株式会社 | ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 |
| JP7175431B1 (ja) | 2021-03-30 | 2022-11-18 | 千寿製薬株式会社 | ヘテロシクリデンアセトアミド誘導体含有懸濁液 |
| CN114646705A (zh) * | 2022-03-22 | 2022-06-21 | 武汉绿合医药科技有限公司 | 一种地夸磷索钠滴眼液有关物质含量检测方法 |
| JP2024043685A (ja) * | 2022-09-20 | 2024-04-02 | 参天製薬株式会社 | ジクアホソルまたはその塩を含有する眼科用組成物のｐＨの低下を抑制する方法 |
| JP7245383B1 (ja) | 2022-09-20 | 2023-03-23 | 参天製薬株式会社 | ジクアホソルまたはその塩を含有する眼科用組成物のｐＨの低下を抑制する方法 |
| KR20250160050A (ko) | 2024-05-03 | 2025-11-11 | 삼천당제약주식회사 | 물리화학적 특성이 개선된 안구건조증 예방 또는 치료용 약학 조성물 |
| CN119970633A (zh) * | 2025-03-26 | 2025-05-13 | 苏州乐珠制药有限公司 | 一种地夸磷索钠滴眼液及其制备方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0365270A (ja) | 1989-07-31 | 1991-03-20 | Kanzaki Paper Mfg Co Ltd | 塗布シートの製造方法 |
| JPH0365270U (enExample) | 1989-10-31 | 1991-06-25 | ||
| US5358706A (en) * | 1992-09-30 | 1994-10-25 | Union Carbide Chemicals & Plastics Technology Corporation | Muco-adhesive polymers |
| CA2125060C (en) * | 1993-07-02 | 1999-03-30 | Henry P. Dabrowski | Ophthalmic solution for artificial tears |
| US5422116A (en) * | 1994-02-18 | 1995-06-06 | Ciba-Geigy Corporation | Liquid ophthalmic sustained release delivery system |
| KR100549904B1 (ko) * | 1996-03-27 | 2006-05-16 | 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 | 우리딘트리포스페이트및관련화합물을함유하는섬모운동장해치료용약학조성물 |
| US5900407A (en) * | 1997-02-06 | 1999-05-04 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with uridine triphosphates and related compounds |
| US6274626B1 (en) * | 1998-12-22 | 2001-08-14 | Bausch & Lomb Incorporated | Pheniramine-containing compositions and method for treating allergic responses |
| WO2001047532A1 (en) * | 1999-12-27 | 2001-07-05 | Santen Pharmaceutical Co., Ltd. | System for stabilizing lacrimal fluid layer |
| AU2001260643B9 (en) * | 2000-05-30 | 2006-10-19 | Merck Sharp & Dohme Corp. | Ectocornea extension promoters |
| KR101389300B1 (ko) * | 2005-02-14 | 2014-04-25 | 존슨 앤드 존슨 비젼 케어, 인코포레이티드 | 안과용 렌즈의 제조방법, 안과용 장치 및 콘택트 렌즈 |
| CA2810481C (en) * | 2010-09-10 | 2018-06-19 | Santen Pharmaceutical Co., Ltd. | Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof |
| US20110052678A1 (en) * | 2010-11-05 | 2011-03-03 | Shantha Totada R | Method for treating age related macular degeneration |
| AU2011350762B2 (en) * | 2010-12-28 | 2017-04-06 | Santen Pharmaceutical Co., Ltd. | Ophthalmic solution containing diquafosol, method for producing same, and method for preventing formation of insoluble precipitate |
| KR20120077080A (ko) | 2010-12-30 | 2012-07-10 | 동우 화인켐 주식회사 | 광학필름 및 이를 이용한 백라이트 유닛 |
| US20160213708A1 (en) * | 2012-01-08 | 2016-07-28 | Medicure Technologies Ltd. | Ophthalmic composition |
| MY169816A (en) * | 2012-03-26 | 2019-05-16 | Santen Pharmaceutical Co Ltd | Ophthalmic solution comprising diquafosol |
| JP2015032653A (ja) | 2013-08-01 | 2015-02-16 | 株式会社東芝 | 固体撮像装置 |
| JP6267003B2 (ja) | 2014-02-27 | 2018-01-24 | 参天製薬株式会社 | ジクアホソルまたはその塩およびレバミピドまたはその塩を組み合わせたことを特徴とする涙液分泌促進剤 |
| EP3139903B1 (en) * | 2014-05-07 | 2019-07-03 | Croma-Pharma Gesellschaft m.b.H. | Aqueous ophthalmic solution and method for treating dry eye syndrome |
| EA034517B1 (ru) * | 2014-12-25 | 2020-02-17 | Сантен Фармасьютикал Ко., Лтд. | Водный офтальмологический раствор |
| WO2016195072A1 (ja) * | 2015-06-05 | 2016-12-08 | 参天製薬株式会社 | ソフトコンタクトレンズが装用されたドライアイ患者の眼に点眼されるように用いられることを特徴とするドライアイ治療剤 |
| CN107837276A (zh) * | 2016-09-19 | 2018-03-27 | 刘力 | 局部给药的药物组合物 |
| SG11202007977RA (en) * | 2018-02-28 | 2020-09-29 | Santen Pharmaceutical Co Ltd | Ophthalmic composition comprising diquafosol and cationic polymer |
| JP6966667B2 (ja) * | 2019-08-27 | 2021-11-17 | 参天製薬株式会社 | ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物 |
-
2020
- 2020-08-25 JP JP2021521065A patent/JP6966667B2/ja active Active
- 2020-08-25 KR KR1020227009546A patent/KR102656181B1/ko active Active
- 2020-08-25 WO PCT/JP2020/031917 patent/WO2021039748A1/ja not_active Ceased
- 2020-08-25 TW TW109128895A patent/TWI848171B/zh active
- 2020-08-25 CN CN202080059970.2A patent/CN114286670B/zh active Active
- 2020-08-25 PH PH1/2022/550474A patent/PH12022550474A1/en unknown
- 2020-08-25 MY MYPI2022001012A patent/MY209059A/en unknown
- 2020-08-25 KR KR1020247011257A patent/KR20240049646A/ko active Pending
- 2020-08-25 CN CN202311818685.6A patent/CN117771172A/zh active Pending
-
2021
- 2021-10-20 JP JP2021171358A patent/JP7614069B2/ja active Active
-
2024
- 2024-12-25 JP JP2024228577A patent/JP7902251B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020138980A5 (enExample) | ||
| JP2013535472A5 (enExample) | ||
| RU2010141542A (ru) | Низковязкие высокофлокулированные суспензии триамцинолона ацетонида для интравитреальных инъекций | |
| CN104334164A (zh) | 基于木糖醇的抗黏膜组合物以及相关方法和组合物 | |
| HRP20230929T1 (hr) | Stabilni pripravci semaglutida i njihova upotreba | |
| JP2017002035A5 (enExample) | ||
| JP2010540619A5 (enExample) | ||
| HRP20250792T1 (hr) | Formulacije anhidriranog natrij tiosulfata | |
| JP2011513492A5 (enExample) | ||
| MY209059A (en) | Aqueous ophthalmic composition comprising diquafosol or salt thereof and polyvinylpyrrolidone | |
| RU2016138577A (ru) | Жидкая фармцевтическая композиция | |
| JP2018529666A5 (enExample) | ||
| JP2022511335A5 (enExample) | ||
| JP2015535237A5 (enExample) | ||
| FI3445331T3 (fi) | Säilöntäainevapaita farmaseuttisia oftalmisia koostumuksia | |
| JP2019530729A5 (enExample) | ||
| JP2023531596A5 (enExample) | ||
| TW201936750A (zh) | 具有釋放活性成分能力的水性組成物及可重複使用之隱形眼鏡產品 | |
| JP2022082779A5 (enExample) | ||
| JP2014515383A5 (enExample) | ||
| JP2022503733A5 (enExample) | ||
| JP2023531725A5 (enExample) | ||
| ES2197781B1 (es) | Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno. | |
| CO2020005939A2 (es) | Composiciones acuosas que comprenden bilastina y mometasona | |
| MX2022005014A (es) | Combinacion de un antagonista de cxcr7 con un modulador del receptor s1p1. |